{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T23:09:00Z","timestamp":1780355340177,"version":"3.54.1"},"reference-count":32,"publisher":"Informa UK Limited","issue":"7","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Ocular Immunology and Inflammation"],"published-print":{"date-parts":[[2025,8,9]]},"DOI":"10.1080\/09273948.2024.2374439","type":"journal-article","created":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T12:17:11Z","timestamp":1721132231000},"page":"1429-1435","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Topical and Subcutaneous Interferon-Alpha for the Treatment of Refractory Inflammatory Macular Edema"],"prefix":"10.1080","volume":"33","author":[{"given":"Michael B.","family":"Green","sequence":"first","affiliation":[{"name":"Boston Medical Center","place":["Boston, USA"]},{"name":"VA Boston Health Care System Jamaica Plain Campus","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Butler","sequence":"additional","affiliation":[{"name":"Boston Medical Center","place":["Boston, USA"]},{"name":"VA Boston Health Care System Jamaica Plain Campus","place":["Boston, USA"]},{"name":"Massachusetts Eye and Ear","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,7,16]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0b013e32834cd5f8"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2024.03.005"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40135-016-0090-3"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2016.115"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2018.1529466"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.08.021"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.56.070187.003455"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2019.1604001"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2019.1687729"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2011.645989"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.iae.0000244265.75771.71"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2023.2195494"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2011.562341"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2019.1585883"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_3210_21"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_2704_20"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1177\/11206721211024809"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2018.03.005"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/95.6.437"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019618"},{"key":"e_1_3_2_22_1","unstructured":"Aman MJ Rudolf G Goldschmitt J Aulitzky WE Lam C Huber C et al. Type-I interferons are potent inhibitors of interleukin-8 production in hematopoietic and bone marrow stromal cells."},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1006\/mvre.1995.1024"},{"key":"e_1_3_2_24_1","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/978-3-642-60411-9_15","article-title":"Adverse effects of interferon treatment","author":"Aul C","year":"1997","unstructured":"Aul C, Gattermann N, Germing U, Heyll A. Adverse effects of interferon treatment. In: Interferons: Biological Activities and Clinical Efficacy. 1997:250\u2013266.","journal-title":"Interferons: Biological Activities and Clinical Efficacy"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-017-3754-2"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2023.2220785"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2022.101504"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002465"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.18502\/jovr.v15i4.7785"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2415-13-63"},{"key":"e_1_3_2_31_1","unstructured":"Intron\u00ae A (interferon alfa-2b) \u2013 Product discontinuation [Internet]. OptumRx. 2022. www.professionals.optumrx.com\/content\/dam\/optum3\/professional-optumrx\/news\/rxnews\/drug-withdrawls\/drugwithdrawal_introna_2022-0204.pdf. 2023."},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000003086"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.4103\/ojo.ojo_146_21"}],"container-title":["Ocular Immunology and Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/09273948.2024.2374439","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T17:47:28Z","timestamp":1773337648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/09273948.2024.2374439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,16]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,8,9]]}},"alternative-id":["10.1080\/09273948.2024.2374439"],"URL":"https:\/\/doi.org\/10.1080\/09273948.2024.2374439","relation":{},"ISSN":["0927-3948","1744-5078"],"issn-type":[{"value":"0927-3948","type":"print"},{"value":"1744-5078","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,16]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ioii20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ioii20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-07-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}